Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Vaccines, Inc.”

61 pharma patents match "Takeda Vaccines, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 61
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 61 pharmaceutical patents matching "Takeda Vaccines, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

61 results for “Takeda Vaccines, Inc.” · 30,257 patents in full index Clear search

  1. US 10806782

    Hand, foot, and mouth vaccines and methods of manufacture and use thereof

    Takeda Vaccines, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  2. US 10792353

    Virus like particle purification

    Takeda Vaccines, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted

  3. US 10688174

    Method of conferring a protective immune response to norovirus

    Takeda Vaccines, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  4. US 10675341

    Parenteral norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  5. US 10632184

    Compositions and methods for stabilizing alphaviruses with improved formulations

    Takeda Vaccines, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  6. US 10525120

    Methods and compositions for live attenuated viruses

    Takeda Vaccines, Inc. · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted

  7. US 10512682

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  8. US 10501500

    Methods of detection and removal of rhabdoviruses from cell lines

    Takeda Vaccines, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  9. US 10233429

    Hand, foot, and mouth vaccines and methods of manufacture and use thereof

    Takeda Vaccines, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  10. US 10172930

    Virus like particle purification

    Takeda Vaccines, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  11. US 10167320

    Purification of virus like particles

    Takeda Vaccines, Inc. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  12. US 10137186

    Compositions and methods for live, attenuated alphavirus formulations

    Takeda Vaccines, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  13. US 10130696

    Method of conferring a protective immune response to norovirus

    Takeda Vaccines, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  14. US 10010599

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  15. US 10010600

    Compositions and methods for administration of vaccines against dengue virus

    Takeda Vaccines, Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  16. US 9890362

    Compositions, methods and uses for inducing viral growth

    Takeda Vaccines, Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  17. US 9878031

    Compositions, methods of administration and uses for trivalent dengue virus formulations

    Takeda Vaccines, Inc. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  18. US 9867876

    Parenteral norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  19. US 9861691

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  20. US 9834757

    Hand, foot, and mouth vaccines and methods of manufacture and use thereof

    Takeda Vaccines, Inc. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  21. US 9821049

    Method of conferring a protective immune response to Norovirus

    Takeda Vaccines, Inc. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  22. US 9801934

    Parenteral norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  23. US 9713638

    Compositions and methods for rapid immunization against dengue virus

    Takeda Vaccines, Inc. · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted

  24. US 9518096

    Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

    Takeda Vaccines, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.